ACTRN12621000003875进行中（未招募）未知
A Dual-Centre Randomised Double-Blind Trial comparing the Arctic Front Advance™ Cryoballoon to the POLARx™ Cryoablation System for Pulmonary Vein Isolation in patients with Atrial Fibrillation.
Dr Nicholas Jackson0 个研究点目标入组 105 人开始时间: 2021年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Age between 17-80 years.
- •Have atrial fibrillation
- •Are referred for AF ablation after failure of at least one antiarrhythmic drug (AAD).
排除标准
- •Pregnant or breastfeeding females.
- •Inability to provide informed consent.
- •Severe left atrial (LA) dilatation (>6cm in diameter)
- •Medical comorbidity where anticoagulation is contra-indicated.
- •Persistent atrial fibrillation for >1 year
研究者
相似试验
进行中（未招募）
不适用
A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression after Coronary Bypass Surgery in Diabetic Patients - THE VICTORY TRIAEUCTR2005-000013-36-ESDr. Olivier F. Bertrand , Laval Hospital280
招募中
不适用
Double-blind Randomized Multi-center Trial Regarding the Effects of Solution for Gemcitabine on Frequency and Degree of Vascular Pain in Patients with CancerJPRN-UMIN000001827Tohoku University Translational Research Center90
已完成
3 期
A phase III study of ONO-4538(ONO-4538-52/TASUKI-52)JPRN-jRCT2080223505ONO PHARMACEUTICAL CO.,LTD.530
已完成
不适用
Randomised double-blind multicentre trial comparing bilateral subthalamic nucleus deep brain stimulation and bilateral globus pallidus deep brain stimulation for advanced Parkinson's diseaseParkinson's diseaseNervous System DiseasesISRCTN85542074Academic Medical Centre (AMC) (Netherlands)128
未知
3 期
A Double-Blind, Randomized, Multicentre Trial Comparing the Efficacy and Tolerability of 250mg of Faslodex (Long Acting ICI 182,780) With 20mg of Nolvadex (Tamoxifen) in Postmenopausal Women With Advanced Breast CancerBreast Cancer MetastasisJPRN-jRCT2080220407AstraZeneca